针对尼古丁胺胺N-甲基转移酶的反感性寡核酸向表现出抗瘤作用
Tomoaki Hara1, Sikun Meng1, Yuuya Kasahara2
1Department of Medical Data Science, Center of Medical Innovation and Translational Research, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Molecular therapy. Nucleic acids
|June 23, 2025
概括
针对尼古丁胺N-甲基转移酶 (NNMT) 的新型反感性寡核酸体显示出作为癌症治疗药物的前景. 这些NNMT抑制剂在临床前模型中有效降低瘤生长,为癌症治疗提供了一种新的方法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 尼古丁胺N-甲基转移酶 (NNMT) 是一种甲基转移酶,参与表观遗传调节和能量代谢.
- 癌症肌层中NNMT表达的增加与预后不佳相关,将其确定为潜在的治疗标.
研究的目的:
- 开发和评估针对癌症治疗的NNMT的新型反感性寡核酸 (ASO).
- 评估针对NNMT的ASO的抗瘤疗效,特别是那些与瘤向剂结合的ASO.
主要方法:
- 产生2',4'-BNA/LNA修饰的盖普尔酸酸抗意义寡核化物来对抗NNMT.
- 在实验室中对癌细胞中NNMT表达抑制的评估.
- 在小鼠癌症细胞移植模型中对抗瘤效应的体内评估.
主要成果:
- 多个ASO候选体显示出在癌细胞中显著抑制NNMT表达.
- 一种的ASO,与向肌体的化合物结合,表现出增强的抗瘤效果.
- 在体内研究证实了针对性ASO治疗小鼠的增强抗瘤活性.
结论:
- 准NNMT的反感性寡核酸有效抑制NNMT的表达和减少瘤生长.
- 针对瘤的NNMT ASO代表了癌症治疗的有前途的新疗法策略.
相关概念视频
Electron Transport Chain: Complex I and II
15.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.1K
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K


